HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aris, A. Articles by Pons-Llado, G. Search for Related Content PubMed PubMed Citation Articles by Aris, A. Articles by Pons-Llado, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 1074-1082, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The Monostrut Bjork-Shiley valve. Seven years' experience

A Aris, JM Padro, ML Camara, O Lapiedra, JM Caralps, X Borras, F Carreras and G Pons-Llado
Cardiac Surgery Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

The results of cardiac valve replacement with the Monostrut Bjork- Shiley prosthesis (Shiley, Inc., Irvine, Calif.) during a 7-year period are presented. A total of 984 valves were implanted in 820 patients from May 1983 to April 1990. Aortic valve replacement was performed in 378 patients, mitral replacement in 294, and multiple replacement in 148. In addition, 180 patients (22%) underwent associated procedures. Mean age was 52.6 +/- 11 years. Operative (30 days) mortality was 5.9% (49 patients): 3.9% (15 patients) for aortic, 7.8% (23 patients) for mitral, and 7.4% (11 patients) for multiple valve replacement. All patients were given long-term anticoagulation therapy. Follow-up was 99% complete (eight patients were lost to follow-up), with a closing interval of 3 months, and totaled 2422 patient-years. Valve-related complications, expressed as percentage event-free (+/- standard error) at seven years were as follows: structural deterioration, 100%; nonstructural dysfunction, 98.3% +/- 0.6%; thromboembolism, 90.2% +/- 1.7%; anticoagulant-related hemorrhage, 88.7% +/- 2.8%; and prosthetic valve endocarditis, 98.1% +/- 0.8%. There were no cases of valve thrombosis. Actuarial survival (free from operative, valve-related, and sudden death) was 88.4% +/- 1.2% at 7 years. Freedom from reoperation was 96.8% +/- 0.1%. Probability of being free from all valve-related morbidity and mortality was 70% +/- 3%, and 708 (93%) of the survivors were in New York Heart Association class I or II. Serial Doppler echocardiograms were done prospectively in 243 patients (with 154 aortic and 120 mitral prostheses), both postoperatively and at regular intervals up to 3 years. Mean prosthetic gradients ranged from an average of 20.9 to 7 mm Hg in the aortic prostheses (21 to 29 mm) and from 6.1 to 4.8 mm Hg in the mitral prostheses (25 to 31 mm). The gradients in each patient did not change significantly during the follow-up period. Our 7 year's experience with the Monostrut valve shows a low rate of valve-related complications, a durable design, and good hemodynamic and functional results.

This article has been cited by other articles:

				C. Huth, A. Friedl, A. Rost, and for the GELIA Study Investigator Group Intensity of oral anticoagulation after implantation of St. Jude Medical aortic prosthesis: analysis of the GELIA Database (GELIA 4) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q33 - Q38. [Abstract] [PDF]

				Y. von Kodolitsch, O. Simic, A. Schwartz, C. Dresler, R. Loose, M. Staudt, J. Ostermeyer, A. Haverich, and C. A. Nienaber Predictors of Proximal Aortic Dissection at the Time of Aortic Valve Replacement Circulation, November 9, 1999; 100(90002): II-287 - 294. [Abstract] [Full Text] [PDF]

				A. Aris, M. L. Camara, J. Montiel, L. J. Delgado, J. Galan, and H. Litvan Ministernotomy versus median sternotomy for aortic valve replacement: a prospective, randomized study Ann. Thorac. Surg., June 1, 1999; 67(6): 1583 - 1587. [Abstract] [Full Text] [PDF]

				A. Aris, A. Igual, J. M. Padro, R. Burgos, J. L. Vallejo, J. M. Rabasa, R. Llorens, and J. Casares The Spanish Monostrut Study Group: A Ten-Year Experience With 8,599 Implants Ann. Thorac. Surg., July 1, 1996; 62(1): 40 - 47. [Abstract] [Full Text]

				A. E. Fiane, K. Saatvedt, J. L. Svennevig, O. Geiran, K. Nordstrand, and T. Froysaker The CarboMedics Valve: Midterm Follow-up With Analysis of Risk Factors Ann. Thorac. Surg., October 1, 1995; 60(4): 1053 - 1058. [Abstract] [Full Text]